Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz ...

South Korea-based Celltrion today announced that the US Food and Drug Administration (FDA) has approved Stoboclo and Osenvelt ...

Previously, Amgen filed patent infringement lawsuits against biosimilar companies including the Swiss Sandoz, South Korea's Celltrion, South Korea's Samsung Bioepis, and Germany's Fresenius Kabi.

Ratings for Amgen AMGN were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...